BNOX Bionomics Ltd

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of July, 2023

(Commission File No. 001-41157)

BIONOMICS LIMITED

(Translation of registrant’s name into English)

200 Greenhill Road

Eastwood SA 5063

Tel: +618 8150 7400

(Address of registrant’s principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):

Yes ☐ No ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):

Yes ☐ No ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☐

 

 

---

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

On July 07, 2023, the Company lodged a Notification of Cessation of Securities in relation to the expiry of unlisted options under the Company's employee incentive plan on Appendix 3H, with the Australian Securities Exchange (ASX) as required by the laws and regulations of Australia, to disclose a change in interests in securities and contracts with the Company. The notifications are furnished herewith as Exhibit 99.1 to this report on Form 6-K.

1

---

 

EXHIBIT INDEX

Exhibit	Description
99.1	Expiry of Unlisted Options - Appendix 3H

 

2

---

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

	Bionomics Limited
	(Registrant)
	By:	/s/ Alan Fisher
	Name:	Alan Fisher.
	Title:	Non-Executive Chairman

Date: July 07, 2023

 

1

---

Exhibit 99.1

	Notification of cessation of +securities

 

Announcement Summary

Entity name

BIONOMICS LIMITED

Announcement Type
New announcement

Date of this announcement
Friday July 07, 2023

Details of +securities that have ceased

 

Number of

ASX +security +securities that The +securities have Date of

code Security description have ceased ceased due to cessation

 

BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	378,600 Expiry of option or other convertible security without exercise or conversion 3,500,000 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied	25/05/2023 30/06/2023

 

Refer to next page for full details of the announcement

 

---

Exhibit 99.1

Notification of cessation of +securities 1 / 4

 

---

Exhibit 99.1

 

	Notification of cessation of +securities

 

Part 1 - Announcement Details

1.1 Name of +Entity
BIONOMICS LIMITED

We (the entity named above) provide the following information about our issued capital.

 

1.2 Registered Number Type ABN

1.3 ASX issuer code BNO

1.4 The announcement is

New announcement

Registration Number

53075582740

1.5 Date of this announcement 7/7/2023

Notification of cessation of +securities 2 / 4

 

---

Exhibit 99.1

 

	Notification of cessation of +securities

 

Part 2 - Details of +equity securities or +debt securities that have ceased

 

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
378,600

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

 

Date of cessation

25/5/2023

Is the entity paying any consideration for the cessation?

No

 

Any other information the entity wishes to notify to ASX about the cessation?

Expiry of non KMP Options

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
3,500,000

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Any other information the entity wishes to notify to ASX about the cessation?

Lapse of Options issued to KMP officer

Date of cessation

30/6/2023

Is the entity paying any consideration for the cessation? No

 

Notification of cessation of +securities 3 / 4

 

---

Exhibit 99.1

	Notification of cessation of +securities

 

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

Total number of

ASX +security code and description +securities on issue

BNO : ORDINARY FULLY PAID 1,468,735,424

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

Total number of

ASX +security code and description +securities on issue

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 117,211,315

BNOAS : WARRANTS 142,000,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities 4 / 4

---

---